sar
outbreak
present
clinician
new
lifethreaten
diseas
experi
treat
research
effect
treatment
option
world
health
organ
expert
panel
sar
treatment
request
systemat
review
comprehens
summari
treatment
use
sarsinfect
patient
order
guid
futur
treatment
identifi
prioriti
research
respons
request
conduct
systemat
review
publish
literatur
ribavirin
corticosteroid
lopinavir
ritonavir
lpvr
type
interferon
ifn
intraven
immunoglobulin
ivig
sar
convalesc
plasma
vitro
studi
sar
patient
also
search
clinic
trial
evid
treatment
acut
respiratori
distress
syndrom
sourc
data
literatur
databas
medlin
embas
biosi
cochran
central
regist
control
trial
central
februari
data
public
extract
evid
within
studi
classifi
use
predefin
criteria
total
sar
treatment
studi
vitro
studi
three
acut
respiratori
distress
syndrom
studi
met
inclus
criteria
within
vitro
studi
ribavirin
lopinavir
type
ifn
show
inhibit
sarscov
tissu
cultur
sarsinfect
patient
report
ribavirin
studi
classifi
inconclus
four
show
possibl
harm
seven
studi
convalesc
plasma
ivig
three
ifn
type
two
lpvr
inconclus
studi
steroid
use
inconclus
four
classifi
caus
possibl
harm
despit
extens
literatur
report
sar
treatment
possibl
determin
whether
treatment
benefit
patient
sar
outbreak
may
harm
clinic
trial
design
valid
standard
protocol
dosag
time
accru
data
real
time
futur
outbreak
monitor
specif
advers
effect
help
inform
treatment
sever
acut
respiratori
syndrom
sar
febril
respiratori
ill
primarili
transmit
respiratori
droplet
close
person
contact
global
outbreak
sar
march
juli
caus
probabl
confirm
case
death
caus
organ
identifi
novel
coronaviru
sarscov
overal
mortal
outbreak
estim
overrid
clinic
featur
sar
rapid
mani
patient
develop
symptom
acut
respiratori
distress
syndrom
ard
complic
occur
approxim
patient
sar
occur
associ
mortal
rate
time
sar
epidem
known
treatment
would
reduc
sarsrel
ill
death
urgenc
intern
outbreak
allow
time
efficaci
studi
physician
canada
hong
kong
treat
earliest
patient
intraven
ribavirin
base
broadspectrum
antivir
activ
corticosteroid
immunemodul
agent
often
prescrib
empir
soon
sarscov
identifi
caus
agent
antivir
screen
program
initi
program
report
sever
antivir
agent
inhibit
sarscov
replic
vitro
result
led
experiment
use
proteas
inhibitor
interferon
alpha
ifna
treatment
patient
commonli
use
treatment
sar
associ
advers
effect
use
condit
tabl
octob
establish
intern
sar
treatment
studi
group
consist
expert
experienc
manag
sar
group
recommend
systemat
review
potenti
treatment
option
identifi
target
proper
evalu
trial
diseas
recur
paper
report
systemat
review
design
summaris
avail
evid
effect
ribavirin
lopinavir
ritonavir
lpvr
corticosteroid
type
ifn
intraven
immunoglobulin
ivig
convalesc
plasma
relat
sarscov
replic
inhibit
vitro
mortal
morbid
sar
patient
effect
ard
adult
patient
prepar
protocol
defin
scope
inclus
criteria
outcom
assess
intervent
includ
defin
ribavirin
lpvr
corticosteroid
type
ifn
convalesc
plasma
ivig
type
studi
includ
vitro
studi
author
examin
inhibit
sarscov
viral
replic
data
assay
human
anim
cell
line
vivo
studi
includ
randomis
control
trial
rct
prospect
uncontrol
studi
design
retrospect
cohort
design
casecontrol
design
case
seri
patient
treat
sar
ten
patient
studi
ard
includ
rct
systemat
review
treatment
ard
acut
lung
injuri
patient
februari
systemat
search
literatur
databas
medlin
embas
biosi
cochran
central
regist
control
trial
central
articl
includ
select
treatment
tabl
full
text
identifi
studi
retriev
independ
review
two
author
ls
rb
public
chines
select
review
english
abstract
unpublish
data
sought
task
summaris
exist
publish
data
extens
intern
sar
treatment
group
indic
much
clinic
data
alreadi
publish
use
quorom
checklist
help
ensur
qualiti
review
tabl
data
full
text
studi
english
extract
independ
two
author
ls
rb
data
chines
literatur
extract
assist
translat
chines
articl
review
one
author
consist
translat
inform
english
articl
maintain
subsequ
discuss
translat
verifi
extract
data
establish
explicit
criteria
assess
level
evid
human
treatment
studi
box
sinc
treatment
chosen
evalu
often
given
combin
evid
classifi
treatment
given
patient
cohort
given
author
intent
studi
effect
put
effect
within
studi
includ
sever
drug
extract
data
intervent
level
evid
independ
classifi
two
author
ls
rb
chines
studi
apprais
classifi
way
use
translat
inform
extract
report
discrep
resolv
consensu
vitro
evid
avail
studi
clinic
evid
sar
treatment
human
report
studi
english
chines
three
studi
address
treatment
ard
figur
vitro
found
six
studi
describ
antivir
effect
ribavirin
vitro
tabl
four
show
antivir
effect
tabl
synergist
antivir
effect
ribavirin
type
ifn
leukocyt
ifna
describ
two
studi
perform
human
cell
line
vero
cell
line
sar
patient
found
studi
describ
ribavirin
treatment
cohort
larger
ten
patient
tabl
formal
assess
classifi
studi
inconclus
due
studi
design
effect
ribavirin
could
distinguish
effect
treatment
steroid
antivir
drug
four
public
present
evid
possibl
harm
three
studi
includ
patient
document
fall
haemoglobin
level
ribavirin
treatment
compar
level
patient
treatment
patient
treat
ribavirin
develop
haemolyt
anaemia
recognis
complic
drug
although
possibl
rule
possibl
sarscov
infect
caus
haemolyt
anaemia
control
group
one
studi
note
sar
patient
degre
liver
dysfunct
indic
alt
level
higher
normal
number
patient
complic
increas
ribavirin
treatment
tabl
chines
literatur
six
addit
report
describ
patient
sar
treat
ribavirin
often
steroid
six
report
determin
inconclus
evalu
treatment
sar
tabl
vitro
three
studi
two
demonstr
lopinavir
inhibit
cytopath
effect
sarscov
fetal
rhesu
monkey
kidney
cell
tabl
one
studi
show
detect
reduc
activ
cell
one
studi
conclud
neither
lopinavir
ritonavir
effect
synergist
effect
lopinavir
ribavirin
report
tabl
sar
patient
found
two
studi
lpvr
lopinavir
mg
ritonavir
mg
oral
everi
h
cohort
larger
ten
patient
tabl
patient
also
receiv
ribavirin
corticosteroid
lpvr
use
compar
among
three
group
patient
receiv
earli
sar
treatment
receiv
late
treatment
receiv
lpvr
ad
initi
treatment
ribavirin
corticosteroid
therapi
death
rate
lower
among
receiv
ribavirin
corticosteroid
studi
determin
inconclus
due
possibl
bia
select
control
group
treatment
alloc
addit
studi
identifi
chines
literatur
vitro
studi
found
cytopath
effect
corticosteroid
alon
sarscov
corticosteroid
act
immunomodulatori
agent
therefor
studi
measur
direct
antivir
effect
vitro
expect
sar
patient
fifteen
articl
examin
corticosteroid
treatment
ten
patient
cohort
also
treat
ribavirin
tabl
determin
studi
inconclus
uncontrol
nonrandomis
studi
patient
treat
highdos
methylprednisolon
mgkg
prednisolon
day
ill
follow
hydrocortisolon
mg
everi
h
pulsedos
methylprednisolon
g
iv
first
week
ill
recov
progress
lung
diseas
tabl
two
studi
contain
evid
possibl
harm
corticosteroid
one
measur
sarscov
plasma
viral
load
across
time
fever
onset
random
doubleblind
placebocontrol
trial
corticosteroid
use
within
first
week
ill
associ
delay
viral
clearanc
studi
casecontrol
found
patient
psychosi
receiv
higher
cumul
dose
steroid
patient
without
psychosi
mg
versu
mg
p
chines
literatur
found
report
steroid
use
tabl
tabl
twelv
studi
inconclus
two
show
possibl
harm
one
studi
report
diabet
onset
associ
methylprednisolon
treatment
anoth
studi
uncontrol
retrospect
studi
sar
patient
report
avascular
necrosi
osteoporosi
among
corticosteroidtr
sar
patient
ard
patient
three
clinic
trial
examin
effect
corticosteroid
mortal
patient
establish
ard
tabl
two
trial
highdos
methylprednisolon
given
approxim
effect
earli
ard
one
small
rct
use
regimen
lower
dose
methylprednisolon
mgkg
per
day
taper
wk
show
possibl
evid
ard
improv
tabl
vitro
twelv
vitro
studi
data
antivir
effect
ifn
type
report
demonstr
antivir
effect
sarscov
six
ifna
ten
ifnb
tabl
antivir
effect
demonstr
monkey
vero
fetal
rhesu
monkey
kidney
human
hpek
cell
line
three
report
present
evid
ifnb
superior
sarscov
compar
ifna
found
virtual
ineffect
sarscov
compar
ifn
synergist
effect
report
leukocyt
ifna
ribavirin
ifnb
ribavirin
ifnb
ifnc
inconclus
studi
could
use
inform
decis
treatment
efficaci
due
either
outcom
report
consist
inconsist
treatment
regimen
control
group
control
group
like
sourc
bia
control
group
consid
like
sourc
bia
differ
comorbid
sex
age
marker
sever
diseas
compar
treatment
group
possibl
harm
studi
report
advers
effect
treatment
consist
advers
effect
report
use
drug
treatment
condit
evid
direct
causal
requir
studi
could
classifi
suggest
possibl
harm
drug
even
studi
methodolog
weak
possibl
benefit
studi
evid
benefit
import
outcom
measur
record
consist
eg
case
fatal
need
mechan
ventil
durat
hospit
frequenc
ard
patient
treat
defin
way
compar
valid
control
group
control
group
consid
valid
random
patient
characterist
ill
sever
compar
treatment
group
evid
direct
causal
requir
definit
harm
studi
contain
statist
signific
evid
harm
demonstr
doubleblind
random
trial
contain
seriou
methodolog
weak
definit
benefit
studi
contain
statist
signific
evid
harm
demonstr
doubleblind
random
trial
contain
seriou
methodolog
weak
sar
patient
two
studi
ifna
given
steroid
andor
ribavirin
report
tabl
signific
differ
seen
outcom
ifna
treatment
group
treat
regimen
result
studi
inconclus
due
lack
consist
treatment
regimen
suitabl
control
group
tabl
chines
literatur
one
addit
studi
report
use
ifna
part
regimen
includ
ribavirin
steroid
determin
studi
inconclus
varieti
treatment
given
mask
effect
ifna
alon
tabl
tabl
vitro
studi
found
cytopath
effect
treatment
sarscov
convalesc
plasma
ivig
act
immunomodulatori
agent
therefor
studi
measur
direct
antivir
effect
vitro
expect
sar
patient
five
studi
either
ivig
convalesc
plasma
treatment
given
addit
steroid
ribavirin
report
treatment
sar
tabl
studi
inconclus
effect
convalesc
plasma
ivig
could
discern
effect
patient
comorbid
stage
ill
effect
treatment
tabl
chines
literatur
two
addit
studi
report
evid
effect
convalesc
plasma
treatment
sar
studi
inconclus
tabl
tabl
evid
collect
benefit
harm
drug
use
treat
sar
summar
tabl
rapid
spread
subsequ
control
sar
preclud
control
clinic
treatment
trial
report
summar
result
systemat
evalu
find
publish
report
treatment
use
sar
epidem
public
chines
literatur
includ
captur
much
evid
possibl
develop
specif
criteria
box
look
larg
obviou
effect
benefit
advers
poor
outcom
evid
potenti
benefit
could
use
prioritis
futur
research
sar
treatment
summari
evid
sar
patient
shown
tabl
despit
thirti
report
sarsinfect
patient
treat
ribavirin
convinc
evid
led
recoveri
haemolyt
anaemia
recogn
side
effect
treatment
observ
three
studi
would
infer
find
futur
use
ribavirin
sar
within
context
control
trial
close
attent
given
advers
effect
corticosteroid
commonli
prescrib
sar
patient
worsen
pulmonari
diseas
progress
abnorm
chest
xray
treatment
regimen
vari
wide
classifi
two
group
earli
treatment
rescu
treatment
given
later
stage
ill
difficult
make
clear
recommend
whether
corticosteroid
use
treat
sarsassoci
lung
injuri
stage
ill
particularli
drug
immunosuppress
may
delay
viral
clearanc
given
viral
replic
control
ad
concern
infecti
complic
avascular
necrosi
steroidinduc
psychosisrecogn
advers
effect
corticosteroid
use
fungal
superinfect
aspergillosi
note
case
report
autopsi
find
sar
patient
given
corticosteroid
high
dose
prolong
period
review
found
evid
avascular
necrosi
steroidinduc
psychosi
sar
patient
seven
studi
treatment
convalesc
plasma
ivig
three
ifn
type
two
lpvr
inconclus
criteria
use
analys
author
four
ivig
studi
comment
patient
seem
improv
upon
treatment
control
trial
approach
need
provid
evid
effect
sar
import
caveat
consid
review
studi
sar
patient
descript
natur
cours
diseas
design
reliabl
assess
effect
treatment
use
patient
characterist
age
presenc
diabet
mellitu
associ
sever
diseas
confound
treatment
effect
diagnost
test
earli
sar
ill
valid
wide
avail
gener
treatment
initi
patient
fulfil
clinic
epidemiolog
case
definit
possibl
inclus
patient
without
laboratori
confirm
sarscov
infect
review
could
caus
underestim
true
effect
antivir
treatment
sar
variat
treatment
regimensparticularli
wide
rang
dose
durat
therapi
rout
administr
ribavirin
corticosteroidsi
major
obstacl
clear
interpret
data
review
nonstandardis
collect
clinic
inform
limit
conclus
drawn
retrospect
analysi
suggest
event
futur
outbreak
sarscov
anoth
novel
agent
attempt
made
develop
treatment
protocol
collect
contribut
inform
standard
minimum
dataset
could
facilit
analysi
treatment
outcom
among
differ
set
observ
studi
pose
problem
interpret
need
great
goodqual
randomis
trial
despit
difficulti
organis
trial
group
recommend
systemat
review
potenti
treatment
sar
particular
consid
import
summaris
avail
evid
use
certain
antivir
drug
ribavirin
lopinavir
ritonavir
steroid
protein
call
immunoglobulin
found
natur
human
blood
group
want
know
treatment
affect
viru
outsid
bodi
vitro
whether
help
condit
patient
reduc
death
rate
particularli
patient
develop
danger
complic
call
acut
respiratori
distress
syndrom
ard
studi
systemat
review
conduct
respons
request
research
find
new
work
patient
laboratori
instead
conduct
comprehens
search
scientif
medic
literatur
publish
studi
fit
care
predefin
select
criteria
found
sar
treatment
studi
vitro
studi
three
ard
studi
met
criteria
vitro
studi
antivir
drug
found
particular
drug
reduc
reproduct
rate
virus
studi
drug
patient
inconclus
studi
steroid
use
inconclus
four
found
treatment
caus
possibl
harm
find
mean
publish
studi
possibl
say
whether
treatment
use
sar
effect
case
sar
report
sinc
alway
possibl
similar
viru
might
caus
outbreak
futur
disappoint
none
research
sar
like
use
help
decid
best
treatment
use
outbreak
author
discuss
weak
studi
found
urg
effect
method
research
appli
time
fashion
similar
outbreak
futur
systemat
review
suggest
know
potenti
treatment
sar
effect
recommend
mean
research
least
better
prepar
learn
potenti
futur
outbreak
addit
inform
pleas
access
web
site
via
onlin
version
summari
http
wikipedia
entri
sar
wikipedia
free
onlin
encyclopedia
anyon
edit
medlineplu
page
sar
wikipedia
entri
systemat
review
includ
link
web
site
detail
inform
may
found
